98%
921
2 minutes
20
Three-dimensional (3D) bioprinting technology offers great potential in the treatment of tissue and organ damage. Conventional approaches generally rely on a large form factor desktop bioprinter to create in vitro 3D living constructs before introducing them into the patient's body, which poses several drawbacks such as surface mismatches, structure damage, and high contamination along with tissue injury due to transport and large open-field surgery. In situ bioprinting inside a living body is a potentially transformational solution as the body serves as an excellent bioreactor. This work introduces a multifunctional and flexible in situ 3D bioprinter (F3DB), which features a high degree of freedom soft printing head integrated into a flexible robotic arm to deliver multilayered biomaterials to internal organs/tissues. The device has a master-slave architecture and is operated by a kinematic inversion model and learning-based controllers. The 3D printing capabilities with different patterns, surfaces, and on a colon phantom are also tested with different composite hydrogels and biomaterials. The F3DB capability to perform endoscopic surgery is further demonstrated with fresh porcine tissue. The new system is expected to bridge a gap in the field of in situ bioprinting and support the future development of advanced endoscopic surgical robots.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131836 | PMC |
http://dx.doi.org/10.1002/advs.202205656 | DOI Listing |
Adv Mater Technol
August 2025
Terasaki Institute for Biomedical Innovation, Los Angeles, CA, USA.
3D bioprinting has emerged as a transformative technology in tissue engineering, significantly impacting the creation of patient-specific tissues to enhance clinical outcomes. Despite its rapid advancement, translating this technology from bench to bedside remains a critical clinical need. New bioprinting approaches, such as handheld printers or robotic arm-driven in-situ biofabrication techniques, have emerged as promising alternatives.
View Article and Find Full Text PDFChem Eng J
September 2025
Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA, United States.
Cardiac patch-based regenerative therapies have shown great promise in the treatment of myocardial infarction (MI). The clinical applications of patch devices, however, face major limitations mainly due to the inadequate integration of typically nonvascular implanted grafts with the recipient heart muscle tissue, the lack of patient and damage specificity, and insufficient perfusion. Here we present a new generation of cardiac patch devices with customized geometry and vasculature to closely correspond to those of the recipient heart tissue, while providing imaging properties.
View Article and Find Full Text PDFSmall
August 2025
School of Biotechnology and Bioengineering, Institute of Advanced Research (IAR), Koba Institutional Area, Gandhinagar, Gujarat, 382426, India.
Chronic and complex wounds pose a major clinical challenge due to the intricate skin architecture and the multifactorial nature of healing. Conventional wound care often fails to restore native skin function and structure. Advances in 3D and 4D bioprinting have transformed wound management by enabling customized, biomimetic skin substitutes that enhance healing.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Mechanical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.
This study presents a novel piston-driven pneumatic extrusion system for direct ink writing (DIW), featuring flexible actuation and real-time monitoring of extrusion pressure. The design integrates the benefits of both pressure and feedrate control, achieving consistent linewidth while safeguarding pressure-sensitive materials such as cell-laden hydrogels. The system comprises a lightweight pneumatic syringe on the printhead and a stationary actuation unit, allowing efficient decoupling of motion and extrusion.
View Article and Find Full Text PDFFront Cell Dev Biol
July 2025
Department of Pediatrics, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Background: Thyroid cancer is the fastest-growing endocrine malignancy globally, with an increasing incidence in younger patients. Conventional therapies, including surgery, radioactive-iodine (RAI) ablation, endocrine suppression, and multi-kinase inhibition, have improved outcomes but are limited by peri-operative morbidity, systemic toxicity, long treatment durations, and the development of drug resistance.
Objective: This review synthesizes current advancements in hydrogel-based therapy, focusing on its potential as a multifunctional platform to overcome the challenges in thyroid cancer management.